Psicología
Departamento
Albert Einstein College of Medicine
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Albert Einstein College of Medicine (21)
2024
-
Optimal hepatitis C treatment adherence patterns and sustained virologic response among people who inject drugs: The HERO study
Journal of Hepatology
-
Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO study
BMC Infectious Diseases, Vol. 24, Núm. 1
-
Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs: The HERO study
International Journal of Drug Policy, Vol. 123
2023
-
Influence of polysubstance use on the health-related quality of life among people who inject drugs undergoing opioid agonist treatment following treatment for hepatitis C virus
Journal of Substance Use
-
Injecting practices during and after hepatitis C treatment and associations with not achieving cure among persons who inject drugs
Drug and Alcohol Dependence, Vol. 247
-
More intensive hepatitis C virus care models promote adherence among people who inject drugs with active drug use: The PREVAIL study
Journal of Viral Hepatitis, Vol. 30, Núm. 2, pp. 172-175
-
Preliminary Evidence of the Association between Time on Buprenorphine and Cognitive Performance among Individuals with Opioid Use Disorder Maintained on Buprenorphine: A Pilot Study
International Journal of Environmental Research and Public Health, Vol. 20, Núm. 16
-
Reduction in Depressive Symptoms in People who Inject Drugs who Are Cured of Hepatitis C Virus Infection: The HERO Study
Open Forum Infectious Diseases, Vol. 10, Núm. 11
2022
-
Changes in Health-related Quality of Life for Hepatitis C Virus-Infected People Who Inject Drugs While on Opioid Agonist Treatment Following Sustained Virologic Response
Clinical Infectious Diseases, Vol. 74, Núm. 9, pp. 1586-1593
-
Changes in alcohol use during hepatitis C treatment in persons who inject drugs
Journal of Viral Hepatitis, Vol. 29, Núm. 11, pp. 1004-1014
-
Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial
The Lancet Gastroenterology and Hepatology, Vol. 7, Núm. 12, pp. 1112-1127
-
Relationship between depressive symptoms and adherence to direct-acting antivirals: Implications for Hepatitis C treatment among people who inject drugs on medications for opioid use disorder
Drug and Alcohol Dependence, Vol. 234
-
Treatment for hepatitis C virus with direct acting antiviral agents: Perspectives and treatment experiences of people who inject drugs
Journal of Substance Abuse Treatment, Vol. 140
2021
-
Hepatitis C Virus Direct-Acting Antiviral Treatment Adherence Patterns and Sustained Viral Response Among People Who Inject Drugs Treated in Opioid Agonist Therapy Programs
Clinical Infectious Diseases, Vol. 73, Núm. 11, pp. 2093-2100
-
Rates of perfect self-reported adherence to direct-acting antiviral therapy and its correlates among people who inject drugs on medications for opioid use disorder: The PREVAIL study
Journal of Viral Hepatitis, Vol. 28, Núm. 3, pp. 548-557
-
Utilizing patient perception of group treatment in exploring medication adherence, social support, and quality of life outcomes in people who inject drugs with hepatitis C
Journal of Substance Abuse Treatment, Vol. 126
2020
-
Declines in depressive symptoms among people who inject drugs treated with direct-acting antivirals while on opioid agonist therapy
Open Forum Infectious Diseases, Vol. 7, Núm. 10, pp. 1-8
-
Factors and HCV treatment outcomes associated with smoking among people who inject drugs on opioid agonist treatment: secondary analysis of the PREVAIL randomized clinical trial
BMC Infectious Diseases, Vol. 20, Núm. 1
-
Low adherence achieves high HCV cure rates among people who inject drugs treated with direct-acting antiviral agents
Open Forum Infectious Diseases, Vol. 7, Núm. 10, pp. 1-3
2019
-
Rationale and design of a randomized pragmatic trial of patient-centered models of hepatitis C treatment for people who inject drugs: The HERO study
Contemporary Clinical Trials, Vol. 87